GB202210507D0 - Virus-like particles, heterodimeric capsid proteins and methods of production thereof - Google Patents

Virus-like particles, heterodimeric capsid proteins and methods of production thereof

Info

Publication number
GB202210507D0
GB202210507D0 GBGB2210507.6A GB202210507A GB202210507D0 GB 202210507 D0 GB202210507 D0 GB 202210507D0 GB 202210507 A GB202210507 A GB 202210507A GB 202210507 D0 GB202210507 D0 GB 202210507D0
Authority
GB
United Kingdom
Prior art keywords
heterodimeric
virus
particles
production
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2210507.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Dundee
Original Assignee
University of Dundee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Dundee filed Critical University of Dundee
Priority to GBGB2210507.6A priority Critical patent/GB202210507D0/en
Publication of GB202210507D0 publication Critical patent/GB202210507D0/en
Priority to PCT/GB2023/051873 priority patent/WO2024018188A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10123—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/10011—Arenaviridae
    • C12N2760/10111—Deltavirus, e.g. hepatitis delta virus
    • C12N2760/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/10011—Arenaviridae
    • C12N2760/10111—Deltavirus, e.g. hepatitis delta virus
    • C12N2760/10123—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/10011—Arenaviridae
    • C12N2760/10111—Deltavirus, e.g. hepatitis delta virus
    • C12N2760/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GBGB2210507.6A 2022-07-18 2022-07-18 Virus-like particles, heterodimeric capsid proteins and methods of production thereof Ceased GB202210507D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2210507.6A GB202210507D0 (en) 2022-07-18 2022-07-18 Virus-like particles, heterodimeric capsid proteins and methods of production thereof
PCT/GB2023/051873 WO2024018188A1 (en) 2022-07-18 2023-07-17 Virus-like particles, heterodimeric capsid proteins and methods of production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2210507.6A GB202210507D0 (en) 2022-07-18 2022-07-18 Virus-like particles, heterodimeric capsid proteins and methods of production thereof

Publications (1)

Publication Number Publication Date
GB202210507D0 true GB202210507D0 (en) 2022-08-31

Family

ID=84540295

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2210507.6A Ceased GB202210507D0 (en) 2022-07-18 2022-07-18 Virus-like particles, heterodimeric capsid proteins and methods of production thereof

Country Status (2)

Country Link
GB (1) GB202210507D0 (en)
WO (1) WO2024018188A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
EP2747774A4 (en) * 2011-09-09 2015-02-11 Biomed Realty L P Methods and compositions for controlling assembly of viral proteins
WO2019222711A1 (en) * 2018-05-17 2019-11-21 Lumen Bioscience, Inc. Arthrospira platensis oral vaccine delivery platform
US20230083273A1 (en) * 2020-02-13 2023-03-16 The Trustees Of Indiana University Hepadnavirus capsid protein heterodimers and virus-like particles

Also Published As

Publication number Publication date
WO2024018188A1 (en) 2024-01-25

Similar Documents

Publication Publication Date Title
WO2007130327A3 (en) Influenza virus-like particle (vlp) compositions
WO2007130330A3 (en) Polyvalent influenza virus-like particle (vlp) compositions
EP4118211A4 (en) Selectable marker proteins, expression vectors, for the production of virus-like particles for therapeutic and prophylactic applications
WO2015158808A3 (en) Recombinant host cell engineered to overexpress helper proteins
WO2008148104A8 (en) Novel vlps derived from cells that do not express a viral matrix or core protein
EP3966277A4 (en) Porous cellulose microparticles and methods of manufacture thereof
NZ741875A (en) Canine parvovirus (cpv) virus-like particle (vlp) vaccines and uses thereof
EP4299766A3 (en) Method for preparing artificial recombinant rotavirus
GB201913355D0 (en) Covalent-organic framework materials and methods of making thereof
PH12020552252A1 (en) Influenza virus hemagglutinin mutants
EP3882351A4 (en) Recombinant vector for expressing virus-like particles in plant and method for preparation of vaccine composition containing circovirus-like particles by using same
PH12018502197A1 (en) Improved method for producing virus like particles
EP4073231A4 (en) Recombinant cdkl5 proteins, gene therapy and production methods
GB202210507D0 (en) Virus-like particles, heterodimeric capsid proteins and methods of production thereof
WO2013003353A3 (en) Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages
EP4087829A4 (en) Ceramic foam-fiber composites, methods of making same, and uses thereof
EP4043030A4 (en) Production method and detection method of african swine fever virus
EP3949992A4 (en) Pharmaceutical composition inhibiting production of hepatitis b virus protein, pharmaceutical composition for treatment of hepatitis b, and screening method
EP3399040A4 (en) Method of preparing porcine circovirus type 2 capsid protein and pharmaceutical composition comprising same
EP4039646A4 (en) Titanium oxide particles, dispersion of titanium oxide particles, and method for producing dispersion of titanium oxide particles
GB202018816D0 (en) Virus-like particles and methods of production thereof
EP4008744A4 (en) Porous cellulose particles and production method therefor
ZA202209860B (en) Virus-like particle (vlp), and preparation method and use thereof
EP4022044A4 (en) Engineered t cells and methods of producing thereof
WO2021067714A3 (en) Methods for determining antibody affinity and binding kinetics using vlps or live viruses attached to biosensors

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)